WebbUpper gastrointestinal tract injury in patients receiving Kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol . 2001;25(5):637-644. doi: 10.1097/00000478-200105000 … Webb21 dec. 2024 · The mean starting SPS pretreatment dose was 0.5 ± 0.2 g/mEq K (range 0.1–1) and the median duration of therapy was 81 days [interquartile range (IQR) 7–227]. Table 1. Demographics and clinical data Ca, calcium; eGFR, estimated glomerular filtration rate; HD, hemodialysis; K, potassium; Na, sodium; PD, peritoneal dialysis; Sim, Similac. …
Kayexalate Uses, Side Effects & Warnings - Drugs.com
Webb27 mars 2024 · You should not use Kayexalate if you have low potassium levels or a bowel obstruction. Do not give this medicine orally (by mouth) to a newborn baby. Avoid taking … WebbKayexalate – We do not recommend oral sodium polystyrene sulfonate ( Kayexalate) because of the impracticality of giving the large dose required and the potential for … definition of arrays
Lokelma: Uses, Dosage, Side Effects, Cost, and More - Healthline
Webb10 feb. 2024 · Hypersensitivity to sodium polystyrene sulfonate, polystyrene sulfonate resins or any component of the formulation; hypokalemia (excluding Kayexalate); … WebbEffets secondaires Kayexalate. o augmentation de l'eau et du taux de sodium dans le sang provoquant des gonflements (rétention hydro-sodé) Troubles digestifs lorsque le médicament est pris par voie orale tels que des brûlures d'estomac, des nausées, des vomissements, une perte de l'appétit et parfois des diarrhées. Webb15 juli 2024 · Lokelma Vs Kayexalate. Lokelma Vs Kayexalate is a comparison of the two potassium binding resins. Lokelma is the brand name of Sodium Zirconium Cyclosilicate marketed by AstraZeneca. Kayexalate is the first and the oldest potassium-binding resin that has been in use since 1958. For the last 60 years or so, Kayexalate was the only … felicity pilot